Cover Image
Market Research Report
Product code 
991393

Asia-pacific Peripheral Vascular Devices Market Forecast 2021-2028

Published: | Inkwood Research | 144 Pages | Delivery time: 2-3 business days

Price

Back to Top
Asia-pacific Peripheral Vascular Devices Market Forecast 2021-2028
Published: March 1, 2021
Inkwood Research
Content info: 144 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The Asia-Pacific peripheral vascular devices market is anticipated to record a CAGR of 11.98% during the forecast period, 2021-2028. The rising prevalence of chronic diseases and the increasing disposable incomes are among the factors that contribute to the market growth.

MARKET INSIGHTS

India, South Korea, China, Japan, Australia & New Zealand, Vietnam, Indonesia, Thailand, and Rest of Asia-Pacific, are analyzed for the Asia-Pacific peripheral vascular devices market growth assessment. Peripheral arterial disease (PAD) is the narrowing of arteries, including thromboangitis obliterans and atherosclerotic PAD. In Japan, as per a study by Yukihito Higashi et al. in Circulation Journal 2016, almost 500,000 to 800,000 had atherosclerotic PAD. Most risk factors evaluated were hypertension, smoking, dyslipidemia, and diabetes mellitus. Moreover, the aging population is more prone to PAD. 28% of the Japanese population is elderly as per 2019 statistics World Bank data Japan. Advanced diagnosis and intense treatments are required to enhance the quality and prognosis of life in the diabetic population, thereby adding burden to Japan's PAD market. The increasing demand for peripheral vascular devices, the aging population, and the high PAD prevalence facilitate market growth in Japan.

With the rising prominence of chronic diseases, Thailand is witnessing a development-associated health-risk transition. Diabetes mellitus (DM) is on the rise, becoming one of the most prevalent chronic diseases. The increasing number of diabetes patients is attributed to unhealthy diets, aging society, and obesity rates. Although the disease detection rate has improved in recent years, glycemic control is still suboptimal. Another major factor is smoking, contributing to 38% of CVD deaths. Such factors make Thailand a potential market for peripheral vascular devices.

COMPETITIVE INSIGHTS

Some of the market's leading companies include, Edwards Lifesciences Corporation, Cardinal Health Inc (CORDIS), Koninklijke Philips NV (Volcano), Medtronic Plc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 36162

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGE IN DEMAND FOR MINIMALLY-INVASIVE PROCEDURES FOR PERIPHERAL ARTERIAL DISEASE
    • 3.1.2. GROWING INCIDENCE OF PERIPHERAL ARTERIAL DISEASE
    • 3.1.3. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. STRINGENT REGULATIONS
    • 3.2.2. LACK OF PROPER REIMBURSEMENT POLICIES FOR PERIPHERAL VASCULAR DEVICES
    • 3.2.3. HIGH COMPETITION

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON PERIPHERAL VASCULAR DEVICES MARKET
  • 4.2. KEY INVESTMENT INSIGHTS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTIONS
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY DEVICE TYPE

  • 5.1. PERIPHERAL VASCULAR STENTS
    • 5.1.1. SELF EXPANDING PERIPHERAL VASCULAR STENTS
    • 5.1.2. BALLOON EXPANDING PERIPHERAL VASCULAR STENTS
    • 5.1.3. DRUG ELUTING PERIPHERAL VASCULAR STENTS
    • 5.1.4. COVERED STENT
  • 5.2. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS
    • 5.2.1. STANDARD PTA BALLOON CATHETERS
    • 5.2.2. HIGH-PRESSURE PTA BALLOON CATHETER
    • 5.2.3. LARGE PTA BALLOON CATHETER
    • 5.2.4. SMALL PTA BALLOON CATHETER
    • 5.2.5. SPECIALTY PTA BALLOON CATHETER
    • 5.2.6. DRUG COATED PTA BALLOON CATHETER
  • 5.3. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES
  • 5.4. ATHERECTOMY DEVICES
  • 5.5. EMBOLIC PROTECTION DEVICES
  • 5.6. INFERIOR VENA CAVA FILTERS
  • 5.7. OTHER DEVICE TYPES

6. GEOGRAPHICAL ANALYSIS

  • 6.1. ASIA-PACIFIC
    • 6.1.1. KEY GROWTH ENABLERS
    • 6.1.2. KEY CHALLENGES
    • 6.1.3. KEY PLAYERS
    • 6.1.4. COUNTRY ANALYSIS
      • 6.1.4.1. CHINA
      • 6.1.4.2. JAPAN
      • 6.1.4.3. INDIA
      • 6.1.4.4. SOUTH KOREA
      • 6.1.4.5. INDONESIA
      • 6.1.4.6. THAILAND
      • 6.1.4.7. VIETNAM
      • 6.1.4.8. AUSTRALIA & NEW ZEALAND
      • 6.1.4.9. REST OF ASIA-PACIFIC

7. COMPETITIVE LANDSCAPE

  • 7.1. KEY STRATEGIC DEVELOPMENTS
    • 7.1.1. MERGER & ACQUISITIONS
    • 7.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 7.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 7.1.4. BUSINESS EXPANSION
  • 7.2. COMPANY PROFILES
    • 7.2.1. ABBOTT LABORATORIES
    • 7.2.2. BOSTON SCIENTIFIC CORPORATION
    • 7.2.3. BECTON, DICKINSON AND COMPANY
    • 7.2.4. COOK GROUP
    • 7.2.5. CARDINAL HEALTH INC (CORDIS)
    • 7.2.6. EDWARDS LIFESCIENCES CORPORATION
    • 7.2.7. MEDTRONIC PLC
    • 7.2.8. KONINKLIJKE PHILIPS NV (VOLCANO)
    • 7.2.9. ANGIOSCORE INC (SPECTRANETICS CORPORATION)
    • 7.2.10. TELEFLEX MEDICAL
    • 7.2.11. TERUMO INTERVENTIONAL SYSTEMS INC
    • 7.2.12. ENDOLOGIX

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - PERIPHERAL VASCULAR DEVICES
  • TABLE 2: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: LEADING PLAYERS OPERATING IN ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 11: LIST OF MERGERS & ACQUISITIONS
  • TABLE 12: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS
  • TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 14: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY DEVICE TYPE, IN 2020
  • FIGURE 6: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 7: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY PERIPHERAL VASCULAR STENTS, IN 2020
  • FIGURE 8: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY SELF EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY BALLOON EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG ELUTING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 11: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY COVERED STENT, 2021-2026 (IN $ MILLION)
  • FIGURE 12: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, IN 2020
  • FIGURE 14: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY STANDARD PTA BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
  • FIGURE 15: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY HIGH-PRESSURE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 16: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY LARGE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 17: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY SMALL PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 18: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY SPECIALTY PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 19: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG COATED PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 20: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES, 2021-2028 (IN $ MILLION)
  • FIGURE 21: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY ATHERECTOMY DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 22: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 23: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY INFERIOR VENA CAVA FILTERS, 2021-2028 (IN $ MILLION)
  • FIGURE 24: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY OTHER DEVICE TYPES, 2021-2028 (IN $ MILLION)
  • FIGURE 25: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 26: CHINA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 27: JAPAN PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 28: INDIA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 29: SOUTH KOREA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: INDONESIA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: THAILAND PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 32: VIETNAM PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 33: AUSTRALIA & NEW ZEALAND PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: REST OF ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)